The Cardiovascular Dimension of Psoriatic Arthritis
Early Arthritis Insights from the CATCH Cohort
Louis Bessette MD, FRCP(C), MSc
Aligning Patient and Physician Perspectives in Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Measuring What Matters in Psoriatic Arthritis
The Next Era of Psoriatic Arthritis Management
Unpacking the Complexity of Psoriatic Arthritis
Lawrence H. Brent
Diagnosing Psoriatic Arthritis: A Real-World Case
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Navigating the Modern PsA Treatment Landscape
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Steve Jackson, PharmD
Marc Scherlinger, MD, PhD
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Ryan Quigley
Luigi Adamo, MD, PhD
Andrea Fava, MD
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.